Pediatrics Vaccines Market Analysis - Global Industry Size, Share, Trends and Forecast, 2014 - 2024

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Forthcoming | Report ID : ARC362

Vaccination is a process or technique of improving the immunity of an individual against any specific infectious or chronic disease. So far, vaccination has saved a large number of lives including children, adults and animals, thus furnishing them with a relatively better and healthier quality of life saving and immunizing them against various infectious microorganisms such as bacteria and virus. This is considered to be one of the most crucial reasons behind the rapid growth of global pediatrics vaccines market over the forecast period. In addition, vaccines are able to stimulate the immune systems of human body in order to protect the concerned individual from subsequent diseases or infections. Vaccines are usually categorized into two main target markets such as pediatric and adult. Pediatric vaccines thus are most commonly employed for proper and efficient immunization of toddlers and children as well as adolescents against several infections such as diphtheria, diseases, hepatitis, influenza, meningococcal diseases and pneumococcal diseases among others.

Rising non-government and government funding associated with the development of vaccines is one of the key factors driving the overall pediatric vaccine market over the forecast period. In addition, advancements in technology such as therapeutic and adjuvant vaccines are further anticipated to fuel the growth of global pediatric vaccines market over the forecast period. Additionally, increasing investments by various players in the market as well as key manufacturers of pediatric vaccines is further increasing the growth of global market. Moreover, increasing inclination of organizations as well as government bodies on immunization schedule prescribed by doctors for the adolescents as well as rising awareness programs led by healthcare organizations such as WHO, UNICEF and others are further projected to bolster the growth of global pediatric vaccines market.

The global pediatric vaccines market can be segmented on the basis of technology, diseases and region. On the basis of technology, the global pediatric vaccines market can be segmented into live attenuated vaccines, recombinant vaccines, inactivated and subunit vaccines, conjugate vaccines, toxoid vaccines. On the basis of diseases, the global pediatric vaccines market can be segmented into diphtheria, hepatitis B, hepatitis A, measles, mumps, polio, rubella, tetanus, varicella, pertussis, influenza and others. On the basis of region, the global pediatric vaccines market can be segmented into North America, Latin America, Europe, Middle East & Africa (MEA) and Asia-Pacific. The robust demand in Asia-Pacific is expected to be the major driving factor for the growth of pediatrics vaccines market. China is anticipated to account for the largest share and lead the overall demand for pediatrics vaccines owing to the increasing industrial production over the last few years. The markets in other developing countries such as Brazil, Russia, Poland, Indonesia, New Zealand, Argentina and India among others are also anticipated to grow rapidly throughout the forecast period.

Major players operating in the global pediatrics vaccines market are focusing on some key market strategies such as mergers and acquisitions to keep hold in the ever competitive market. Moreover, they are concentrating on collaborating with local players to increase their market reach as well as strengthen their goodwill in the global market. Some of the major players in global pediatrics vaccines system market include Sanofi, Novartis AG., Amgen Inc., Abbott Laboratories, AstraZeneca Plc, Shire Pharmaceuticals Group Plc, F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, Merck & Co. Inc, Eli Lilly and Company, GlaxoSmithKline, Genentech Inc., Shire Pharmaceuticals Group Plc, Actelion Pharmaceuticals Ltd, Shire Pharmaceuticals Group Plc and Abbott Laboratories among others.

Market Segmentation

Market by Technology

·         Live Attenuated Vaccines

·         Recombinant Vaccines

·         Inactivated and Subunit Vaccines

·         Conjugate Vaccines

·         Toxoid Vaccines

Market by Disease

·         Diphtheria

·         Hepatitis B

·         Hepatitis A

·         Measles

·         Polio

·         Influenza

·         Others (Tetanus, Varicella, Pertussis, Rubella, Mumps, etc.)

Market by Geography

·         North America

o   US

o   Canada

o   Mexico

·         Europe

o   UK

o   Germany

o   France

o   Rest of Europe

·         Asia-Pacific

o   China

o   Japan

o   India

o   Philippines

o   Rest of Asia-Pacific

·         Latin America

o    Brazil

o   Chile

o   Rest of Latin America

·         Middle East and Africa (MEA)

o   South Africa

o   Saudi Arabia

o   Rest of MEA


Related Reports

Tumor Necrosis Factor (TNF) Inhibitor Drugs Market (By Product: Simponi/Simponi Aria, Remicade, Enbrel, Cimzia, Humira, Biosimilars; By Application: Psoriatic Arthritis, Crohn’s Disease, Rheumatoid Arthritis, Psoriasis, Juvenile Idiopathic Arthritis, Hidradenitis Suppurativa, Ulcerative Colitis, Ankylosing Spondylitis, Others; By Sales Channel: Online Pharmacies, Specialty Pharmacies, Hospital Pharmacies) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global TNF Inhibitor Drugs market is forecasted to grow at striking CAGR around 0.6% over the forecast time frame and reach around US$ 41 billion by 2026. TNF inhibitors or factor inhibitors of tumor necrosis are biological medicines extracted from human or animal tissue, most frequently used to preve

Scleroderma Therapeutics Market (By Drug Class: Immunosuppressors, Endothelin Receptor Antagonists, Phosphodiesterase 5 Inhibitors - PHA, Calcium Channel Blockers, Analgesic, Prostacyclin Analogues, Others; By Indication: Systemic, Localized) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global scleroderma therapeutics market is forecasted to grow at striking CAGR around 6.4% over the forecast time frame and reach around US$ 3.8 billion by 2026. It is an autoimmune rheumatic condition which causes the skin and connective tissues to get chronically hardened and tightened. However, it i

Orthopedic Biomaterials Market (By Material Type: Calcium Phosphate Cements, Ceramics & Bioactive Glasses, Polymers, Composites, Metal; By Application: Joint Replacement/Reconstruction, Orthopedic Implants, Viscosupplementation, Bio-resorbable Tissue Fixation, Orthobiologics) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global orthopedic biomaterials market size is expected to reach around US$ 26 billion by 2026 growing at noteworthy CAGR around 10.0 % throughout the forecast period 2019 to 2026. Organic or synthetic biomaterials used for inner fracture fixation are biological materials of biological structure. For m

Oral Irrigator Market (By Type: Countertop, Cordless; By Application: Home, Dentistry) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global oral irrigator market value is expected to reach around US$ 1 billion by 2026 growing at CAGR around 3.6% over the forecast time frame 2019 to 2026. The device used to remove plaque and debris from between teeth is dental water or oral water irrigation. This method is carried out with a pulse w

Irritable Bowel Syndrome Treatment Market (By Type: IBS-D [Viberzi, Xifaxan, Others], IBS-C [Amitiza, Linzess/Constella, Others]; By Product: Viberzi, Linzess/Constella, Xifaxan, Amitiza, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Irritable Bowel Syndrome Treatment market is expected to grow at noteworthy CAGR around 9.8 % throughout the forecast period and reach around US$ 3.4 billion by 2026. IBS is a gastrointestinal functional disorder of the intestine that is characterized by contractions of the colon muscle. The bi

Cart Summary